Clostridium difficile infection in hospitalized liver transplant patients: A nationwide analysis

Liver Transplantation

Volumn 18, Issue 8, 2012, Pages 972-978

  Ali, Muhammad ^a   Ananthakrishnan, Ashwin N ^b   Ahmad, Shahryar ^a   Kumar, Nilay ^a   Kumar, Gagan ^a   Saeian, Kia ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENTERITIS; FEMALE; HOSPITAL COST; HOSPITAL PATIENT; HUMAN; ICD-9; LENGTH OF STAY; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NASOGASTRIC TUBE; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; HOSPITALIZATION; HUMANS; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84864420616     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23449     Document Type: Article

References (34)

1. Khanna S, Pardi DS,. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev Gastroenterol Hepatol 2010; 4: 409-416.
2. Dubberke ER, Butler AM, Yokoe DS, Mayer J, Hota B, Mangino JE, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol 2010; 31: 1030-1037.
3. Smith LC, Ratard R,. Clostridium difficile hospitalizations in Louisiana: a 10 year review. J La State Med Soc 2011; 163: 192-195.
4. Ananthakrishnan AN, McGinley EL, Saeian K, Binion DG,. Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 976-983.
5. Tonna I, Welsby PD,. Pathogenesis and treatment of Clostridium difficile infection. Postgrad Med J 2005; 81: 367-369. (Pubitemid 40834901)
6. Kelly CP, LaMont JT,. Clostridium difficile-more difficult than ever. N Engl J Med 2008; 359: 1932-1940.
7. Ananthakrishnan AN,. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol 2011; 8: 17-26.
8. Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011; 365: 1693-1703.
9. McDonald G, Owens M,., Chapter 15: Gastrointestinal infections after hematopoietic stem cell or solid organ transplant. In:, Bowden RA, Ljungman P, Paya CV, eds. Transplant Infections. Philadelphia, PA: Lippincott Williams & Wilkins; 2003: 198-221.
10. Niemczyk M, Leszczyńiski P, Wyzgał J, Paczek L, Krawczyk M, Luczak M,. Infections caused by Clostridium difficile in kidney or liver graft recipients. Ann Transplant 2005; 10: 70-74.
11. Lee M, Shelton AA, Concepcion WL, Bonham CA, Daugherty TJ,. Fulminant Clostridium difficile colitis in a post-liver transplant patient. Dig Dis Sci 2010; 55: 2459-2462.
12. Albright JB, Bonatti H, Mendez J, Kramer D, Stauffer J, Hinder R, et al. Early and late onset Clostridium difficile-associated colitis following liver transplantation. Transpl Int 2007; 20: 856-866. (Pubitemid 47390196)
13. Hashimoto M, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Togashi J, Makuuch M,. Clostridium difficile-associated diarrhea after living donor liver transplantation. World J Gastroenterol 2007; 13: 2072-2076. (Pubitemid 46795844)
14. Stelzmueller I, Goegele H, Biebl M, Wiesmayr S, Berger N, Tabarelli W, et al. Clostridium difficile colitis in solid organ transplantation-a single-center experience. Dig Dis Sci 2007; 52: 3231-3236. (Pubitemid 47512550)
15. Healthcare Cost and Utilization Project. Overview of the Nationwide Inpatient Sample. http://www.hcup-us.ahrq.gov/nisoverview.jsp Accessed November 2011 and March 2012.
16. Dubberke ER, Butler AM, Nyazee HA, Reske KA, Yokoe DS, Mayer J, et al.; for Centers for Disease Control and Prevention Epicenters Program. The impact of ICD-9-CM code rank order on the estimated prevalence of Clostridium difficile infections. Clin Infect Dis 2011; 53: 20-25.
17. Dubberke ER, Butler AM, Yokoe DS, Mayer J, Hota B, Mangino JE, etal.; for Prevention Epicenters Program of the Centers for Disease Control and Prevention. Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes. Infect Control Hosp Epidemiol 2010; 31: 262-268.
18. Bajaj JS, Ananthakrishnan AN, Hafeezullah M, Zadvornova Y, Dye A, McGinley EL, et al. Clostridium difficile is associated with poor outcomes in patients with cirrhosis: a national and tertiary center perspective. Am J Gastroenterol 2010; 105: 106-113.
19. Bajaj JS, Ananthakrishnan AN, McGinley EL, Hoffmann RG, Brasel KJ,. Deleterious effect of cirrhosis on outcomes after motor vehicle crashes using the Nationwide Inpatient Sample. Am J Gastroenterol 2008; 103: 1674-1681.
20. Csikesz NG, Simons JP, Tseng JF, Shah SA,. Surgical specialization and operative mortality in hepato-pancreatico-biliary (HPB) surgery. J Gastrointest Surg 2008; 12: 1534-1539.
21. Scarborough JE, Tuttle-Newhall JE, Pietrobon R, Marroquin CE, Collins BH, Desai DM, et al. Supply and demand for liver transplant surgery: are we training enough surgeons? HPB (Oxford) 2008; 10: 25-29. (Pubitemid 351298108)
22. Deyo RA, Cherkin DC, Ciol MA,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619.
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383. (Pubitemid 17055592)
24. Martin GS, Mannino DM, Eaton S, Moss M,. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554. (Pubitemid 36437931)
25. Bignardi GE,. Risk factors for Clostridium difficile infection. J Hosp Infect 1998; 40: 1-15. (Pubitemid 28438966)
26. Ananthakrishnan AN, Issa M, Binion DG,. Clostridium difficile and inflammatory bowel disease. Med Clin North Am 2010; 94: 135-153.
27. Ananthakrishnan AN, McGinley EL, Binion DG,. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008; 57: 205-210. (Pubitemid 351158048)
28. Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007; 5: 345-351. (Pubitemid 46401531)
29. Wong NA, Bathgate AJ, Bellamy CO,. Colorectal disease in liver allograft recipients-a clinicopathological study with follow-up. Eur J Gastroenterol Hepatol 2002; 14: 231-236. (Pubitemid 34259270)
30. Poutanen SM, Simor AE,. Clostridium difficile-associated diarrhea in adults. CMAJ 2004; 171: 51-58. (Pubitemid 38925121)
31. Bartlett JG, Gerding DN,. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008; 46 (suppl 1): S12-S18. (Pubitemid 351323661)
32. Gerding DN,. Clostridium difficile 30 years on: what has, or has not, changed and why? Int J Antimicrob Agents 2009; 33 (suppl 1): S2-S8.
33. West M, Pirenne J, Chavers B, Gillingham K, Sutherland DE, Dunn DL, Matas AJ,. Clostridium difficile colitis after kidney and kidney-pancreas transplantation. Clin Transplant 1999; 13: 318-323. (Pubitemid 29392622)
34. Crabtree TD, Pelletier SJ, Gleason TG, Pruett TL, Sawyer RG,. Clinical characteristics and antibiotic utilization in surgical patients with Clostridium difficile-associated diarrhea. Am Surg 1999; 65: 507-511.